AKT1 and breast cancer: These results indicate that Rh1 possesses potential antitumor properties in BC in vivo and further confirmed the in vitro results, in which Rh1 induced autophagy, apoptosis, and cell cycle arrest through ROS-mediated Akt inhibition.